Australian Institute of Health and Welfare (2020) Impacts of COVID-19 on Medicare Benefits Scheme and Pharmaceutical Benefits Scheme service use, AIHW, Australian Government, accessed 29 May 2023.
Australian Institute of Health and Welfare. (2020). Impacts of COVID-19 on Medicare Benefits Scheme and Pharmaceutical Benefits Scheme service use. Retrieved from https://www.aihw.gov.au/reports/health-care-quality-performance/covid-impacts-on-mbs-and-pbs
Impacts of COVID-19 on Medicare Benefits Scheme and Pharmaceutical Benefits Scheme service use. Australian Institute of Health and Welfare, 17 December 2020, https://www.aihw.gov.au/reports/health-care-quality-performance/covid-impacts-on-mbs-and-pbs
Australian Institute of Health and Welfare. Impacts of COVID-19 on Medicare Benefits Scheme and Pharmaceutical Benefits Scheme service use [Internet]. Canberra: Australian Institute of Health and Welfare, 2020 [cited 2023 May. 29]. Available from: https://www.aihw.gov.au/reports/health-care-quality-performance/covid-impacts-on-mbs-and-pbs
Australian Institute of Health and Welfare (AIHW) 2020, Impacts of COVID-19 on Medicare Benefits Scheme and Pharmaceutical Benefits Scheme service use, viewed 29 May 2023, https://www.aihw.gov.au/reports/health-care-quality-performance/covid-impacts-on-mbs-and-pbs
The below resources contain further information about the impacts of COVID-19.
This website needs JavaScript enabled in order to work correctly; currently it looks like it is disabled. Please enable JavaScript to use this website as intended.
We'd love to know any feedback that you have about the AIHW website, its contents or reports.
The browser you are using to browse this website is outdated and some features may not display properly or be accessible to you. Please use a more recent browser for the best user experience.